Methadone-related deaths in Norway

Forensic Science International

Volumn 224, Issue 1-3, 2013, Pages 111-116

  Bernard, Jean Paul ^a,b   Havnes, Ingrid ^c,d   Slørdal, Lars ^e,f   Waal, Helge ^c   Mørland, Jørg ^a,c   Khiabani, Hassan Z ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Methadone; Opioids; Overdose; Toxicity

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; DIAZEPAM; FLUNITRAZEPAM; METHADONE; MORPHINE; OPIATE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOPSY; DEMOGRAPHY; DRUG INTOXICATION; EPIDEMIOLOGICAL DATA; FEMALE; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METHADONE TREATMENT; MORTALITY; NORWAY; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84872425794     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.11.010     Document Type: Article

References (29)

1. Dole V.P., Nyswander M. Study of methadone as an adjunct in rehabilitation of heroin addicts. IMJ. Ill. Med. J. 1966, 130:487-489.
2. Anchersen K., Clausen T., Gossop M., Hansteen V., Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009, 104:993-999.
3. Ehret G.B., Voide C., Gex-Fabry M., Chabert J., Shah D., Broers B., Piguet V., Musset T., Gaspoz J.M., Perrier A., Dayer P., Desmeules J.A. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch. Intern. Med. 2006, 166:1280-1287.
4. Katchman A.N., McGroary K.A., Kilborn M.J., Kornick C.A., Manfredi P.L., Woosley R.L., Ebert S.N. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J. Pharmacol. Exp. Ther. 2002, 303:688-694.
5. Kornick C.A., Kilborn M.J., Santiago-Palma J., Schulman G., Thaler H.T., Keefe D.L., Katchman A.N., Pezzullo J.C., Ebert S.N., Woosley R.L., Payne R., Manfredi P.L. QTc interval prolongation associated with intravenous methadone. Pain 2003, 105:499-506.
6. Peles E., Bodner G., Kreek M.J., Rados V., Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction 2007, 102:289-300.
7. Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008, 94:151-157.
8. Bell J., Zador D. A risk-benefit analysis of methadone maintenance treatment. Drug Safety 2000, 22:179-190.
9. Methadone as an Essential Medicine for the Management of Opioid Dependence, Proposal for the Inclusion of Methadone in the WHO Model List of Essential Medicines, Department of Mental Health and Substance Abuse, Management of Substance Abuse, HIV/AIDS Department, WHO, 2004 (Ref Type: Report).
10. Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst. Rev. 2003, CD002208.
11. Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2008, CD002207.
12. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 2009, CD002209.
13. Graham N.A., Merlo L.J., Goldberger B.A., Gold M.S. Methadone- and heroin-related deaths in Florida. Am. J. Drug Alcohol Abuse 2008, 34:347-353.
14. Luty J., O'Gara C., Sessay M. Is methadone too dangerous for opiate addiction?. Br. Med. J. 2005, 331:1352-1353.
15. Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther. Drug Monit. 2002, 24:457-470.
16. H. Waal, T. Clausen, C. Aamodt, P.H. Lillevold, Medication-Assisted Rehabilitation in Norway, Status Report 2006, University of Oslo, Oslo, 2007 (Ref Type: Report).
17. Statistics Norway, SSB, 2011 (Ref Type: Electronic Citation).
18. EMCDDA National Report 2010: Norway, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 2011 (Ref Type: Report).
19. Vormfelde S.V., Poser W. Death attributed to methadone. Pharmacopsychiatry 2001, 34:217-222.
20. Strang J., Hall W., Hickman M., Bird S.M. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland. Br. Med. J. 2010, 341:c4851.
21. Morgan O., Griffiths C., Hickman M. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int. J. Epidemiol. 2006, 35:1579-1585.
22. Barnhart F.E., Bonnell H.J., Rossum K.M. Postmortem drug redistribution. Forensic Sci. Rev. 2001, 13:101-129.
23. Ferner R.E. Post-mortem clinical pharmacology. Br. J. Clin. Pharmacol. 2008, 66:430-443.
24. Bernard J.P., Morland J., Krogh M., Khiabani H.Z. Methadone and impairment in apprehended drivers. Addiction 2009, 104:457-464.
25. Caplehorn J.R., Drummer O.H. Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines. Aust. N. Z. J. Public Health 2002, 26:358-362.
26. Lintzeris N., Nielsen S. Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am. J. Addict. 2010, 19:59-72.
27. Jones A.W., Holmgren A., Ahlner J. Blood methadone concentrations in living and deceased persons: variations over time, subject demographics, and relevance of coingested drugs. J. Anal. Toxicol. 2012, 36:12-18.
28. National Clinical Guideline for the Pharmacologically Assisted Rehabilitation of Opioid Dependency, Norwegian Directorate of Health, 2010 (Ref Type: Report).
29. Bramness J.G., Kornor H. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend. 2007, 90:203-209.